Advances in HIV Treatment and Prevention

11:00 AM - 12:15 PM, Tuesday, June 4, 2019 ・ 115C, Level 100
This session will showcase new scientific and clinical data on novel vaccines and immunotherapies to prevent and/or treat HIV. Panelists will discuss how the public health community will balance prevention versus treatment with these new advances, the scientific difficulty in conquering this complex disease and how industry and partner business models will need to differ for developed and developing country markets.
Senior Director, Global Clinical Development/HIV & STI Vaccines
Johnson & Johnson
Vice-President and Therapeutic Area Head, Infectious Disease And Vaccines, CSO, Merck Cambridge Exploratory Science Center, Merck Research Labs
Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub